ConductScience.org, home

Trial · NCT03246399

Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySafety and tolerability: treatment emergent adverse events (TEAEs)Day 180Evaluate the safety and tolerability of SM04690 Injectable Suspension as measured by TEAEs during the entire treatment and observation period
PrimarySafety and tolerability: change from baseline in electrocardiogram (ECG) parametersBaseline and Day 180Evaluate the safety and tolerability of SM04690 Injectable Suspension as measured by change from baseline in ECG parameters
PrimarySafety and tolerability: change from baseline in physical examinationBaseline and Day 180
Evaluate the safety and tolerability of SM04690 Injectable Suspension as measured by change from baseline in physical examination (number of subjects with clinically significant change in physical examination)
PrimarySafety and tolerability: change from baseline in clinical laboratory testsBaseline and Day 180
Evaluate the safety and tolerability of SM04690 Injectable Suspension as measured by change from baseline in clinical laboratory tests (number of subjects with clinically significant changes in laboratory test parameters)
PrimarySafety and tolerability: change from baseline in vital signsBaseline and Day 180Evaluate the safety and tolerability of SM04690 Injectable Suspension as measured by change from baseline in vital signs (number of subjects with clinically significant changes in vital signs)
PrimaryIncidence of dose-limiting toxicities (DLTs)Day 180Evaluate incidence and severity of DLTs in each cohort
PrimaryPharmacokinetics (PK) of SM04690: CmaxDay 1Maximum plasma concentration (Cmax) estimate for a single intradiscal injection of SM04690 Injectable Suspension
PrimaryPK of SM04690: tmaxDay 1Time to Cmax estimate for a single intradiscal injection of SM04690 Injectable Suspension
PrimaryPK of SM04690: AUCDay 1Area under the plasma-concentration time curve (AUC) estimate for a single intradiscal injection of SM04690 Injectable Suspension
PrimaryPK of SM04690: half-lifeDay 1Plasma terminal phase half-life estimate for a single intradiscal injection of SM04690 Injectable Suspension
SecondaryChange in spine bone mineral densityBaseline and Day 180Evaluate change from baseline spine bone mineral density as measured by dual-energy x-ray absorptiometry (DXA)
SecondaryChange in hip bone mineral densityBaseline and Day 180Evaluate change from baseline hip bone mineral density as measured by DXA
OtherChange in lumbar back painBaseline and Day 180Evaluate change from baseline lumbar back pain using the Visual Analog Scale (VAS)
OtherChange in disabilityBaseline and Day 180Evaluate change from baseline disability as measured by Oswestry disability index (ODI)
OtherChange in disease activity by physician assessmentBaseline and Day 180Evaluate change from baseline disease activity using Physician Global Assessment (PGA)
OtherChange in treated intervertebral discsBaseline and Day 180Evaluate change from baseline in treated intervertebral discs by modified Pfirrmann grade using Magnetic Resonance Imaging (MRI)
OtherChange in disc space heightBaseline and Day 180Evaluate change from baseline in disc space height by radiograph

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03246399/registered